ReShape Lifesciences Inc. (RSLS)
RSLS Stock Price Chart
Explore ReShape Lifesciences Inc. interactive price chart. Choose custom timeframes to analyze RSLS price movements and trends.
RSLS Company Profile
Discover essential business fundamentals and corporate details for ReShape Lifesciences Inc. (RSLS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
6 Oct 2016
Employees
17.00
CEO
Paul F. Hickey
Description
ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract. It also offers ReShapeCare virtual health coaching program, a virtual telehealth weight management program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. In addition, the company provides Obalon Balloon System, a swallowable capsule used to track and display the location of the balloon during placement. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.
RSLS Financial Timeline
Browse a chronological timeline of ReShape Lifesciences Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 18 May 2026
Upcoming earnings on 13 Nov 2025
Stock split effective on 15 Aug 2025
Shares were split 1 : 4 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 Aug 2025
EPS came in at -$2.25 , while revenue for the quarter reached $1.24M .
Earnings released on 20 May 2025
EPS came in at $18.98 , while revenue for the quarter reached $1.11M .
Stock split effective on 9 May 2025
Shares were split 1 : 25 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 4 Apr 2025
EPS came in at -$47.25 surpassing the estimated -$101.50 by +53.45%, while revenue for the quarter reached $1.81M , missing expectations by -43.11%.
Earnings released on 14 Nov 2024
EPS came in at -$3.11 surpassing the estimated -$5.80 by +46.38%, while revenue for the quarter reached $2.29M , missing expectations by -8.61%.
Stock split effective on 23 Sept 2024
Shares were split 1 : 58 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 Aug 2024
EPS came in at -$3.49 surpassing the estimated -$6.96 by +49.86%, while revenue for the quarter reached $1.97M , missing expectations by -11.09%.
Earnings released on 15 May 2024
EPS came in at -$5.23 falling short of the estimated -$0.16 by -3.17K%, while revenue for the quarter reached $1.94M , missing expectations by -7.43%.
Earnings released on 23 Feb 2024
EPS came in at -$0.11 surpassing the estimated -$0.18 by +38.89%, while revenue for the quarter reached $1.98M .
Earnings released on 8 Nov 2023
EPS came in at -$59.30 falling short of the estimated -$1.20 by -4.84K%, while revenue for the quarter reached $2.16M , missing expectations by -2.49%.
Earnings released on 7 Aug 2023
EPS came in at -$62.79 falling short of the estimated -$1.79 by -3.41K%, while revenue for the quarter reached $2.25M , missing expectations by -6.08%.
Earnings released on 15 May 2023
EPS came in at -$90.70 falling short of the estimated -$4.21 by -2.05K%, while revenue for the quarter reached $2.29M , missing expectations by -8.88%.
Earnings released on 29 Mar 2023
EPS came in at -$8.59 surpassing the estimated -$10.00 by +14.10%, while revenue for the quarter reached $3.11M , beating expectations by +0.32%.
Stock split effective on 23 Dec 2022
Shares were split 1 : 50 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 Nov 2022
EPS came in at -$552.33 falling short of the estimated -$17.75 by -3.01K%, while revenue for the quarter reached $2.80M , missing expectations by -22.64%.
Earnings released on 19 Aug 2022
EPS came in at -$1.19K falling short of the estimated -$18.00 by -6.52K%, while revenue for the quarter reached $2.89M , missing expectations by -15.15%.
Earnings released on 23 May 2022
EPS came in at -$1.10K falling short of the estimated -$17.00 by -6.40K%, while revenue for the quarter reached $2.44M , missing expectations by -24.28%.
Earnings released on 28 Mar 2022
EPS came in at $145.35 surpassing the estimated -$8.50 by +1.81K%, while revenue for the quarter reached $3.14M , missing expectations by -15.98%.
Earnings released on 11 Nov 2021
EPS came in at -$901.16 falling short of the estimated -$7.50 by -11.92K%, while revenue for the quarter reached $3.71M .
Earnings released on 16 Aug 2021
EPS came in at -$436.05 , while revenue for the quarter reached $3.53M .
Stock split effective on 16 Jun 2021
Shares were split 1 : 3 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 12 May 2021
EPS came in at -$3.84K falling short of the estimated -$26.50 by -14.38K%, while revenue for the quarter reached $3.22M , beating expectations by +47.22%.
Earnings released on 12 Mar 2021
EPS came in at -$1.48K falling short of the estimated -$22.00 by -6.64K%, while revenue for the quarter reached $3.21M .
Earnings released on 6 Nov 2020
EPS came in at -$1.74K , while revenue for the quarter reached $3.60M .
RSLS Stock Performance
Access detailed RSLS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.